Zhejiang Hisun Pharmaceutical Co., Ltd.

¥13.40As of Sun 8 Nov 2026, 12:00 UTC
SSE:600267Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 0.15%
Div yield 1.57%
ROE 13.32%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.30
PE TTM 12.89
TSR TTM 22.06%
Mkt cap ¥15.52B
ROIC 11.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥14
5.00%
(88.03%)
Hold 5|12|8|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.16
0.17
0.18
23.66%
21.81%
33.64%
30.55%
Revenue¥B
1.277
1.335
1.356
1.378
(0.15%)
7.09%
11.72%
9.53%
Peers (US$2.327B)
Cap (US$)
PE
2.349B
56.11x
2.334B
28.62x
2.190B
17.45x
Capital
TTM
5Y
10Y
Leveragex
0.566
0.181
0.147
EBIT/Intx
0.576
0.075
0.085
Own earn%
18.87
(11.64)
(8.10)
Sh yield%
24.55
42.94
42.20
Owners
Insiders/Inst%
11.77
81.84
Short interest%
5.35
SBC / revenue%
1.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–12
$1 testx
0.0
Incr. ROIC%
16